ArticlePloS one2024

Cost-effectiveness analysis of COVID-19 booster doses and oral antivirals: Case studies in the Indo-Pacific.

Gizem Mayis Bilgin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.